One in every five reptile species is now threatened with extinction, a figure that is growing at an accelerating rate driven by the pet trade and smuggling.
One in every five reptile species is now threatened with extinction, a figure that is growing at an accelerating rate driven by the pet trade and smuggling.
Where this was said
At 1:49:56 · chapter starts 1:26:40
Joe Rogan's shock is palpable when Eric Goode walks him through the economics of the turtle trade. Golden coin turtles (Cuora trifasciata) sell for $20,000 to $40,000 each in China, where they are consumed for their alleged medicinal properties — purportedly curing cancer and other diseases. [1] — Eric Goode "Golden coin turtles sell for $20,000 to $40,000 in China. Yunnan box turtles — once thought extinct for 50 years — can fetch $100,000 or mo…" 1:53:10 The Yunnan box turtle, thought extinct for more than half a century and recently rediscovered, commands $100,000 or more. Wild-caught specimens are worth dramatically more than farmed ones because Asian buyers believe wild animals accumulate more medicinal potency from their diet — a logic parallel to wild rhino horn versus farmed horn. Eric describes 15-story turtle farm buildings in China and vast indoor turtle markets where rare US native turtles — wood turtles, spotted turtles, three-toed box turtles from Missouri and Oklahoma — arrive stuffed in socks in luggage, valued at half a million dollars a shipment once they clear customs in Hong Kong. The scale of this trade, Eric argues, eclipses the more visible rhino horn and ivory markets in sheer per-pound value.
One in every five reptile species is now threatened with extinction, and that number is growing. The exotic pet trade, habitat loss, and illegal smuggling are all accelerating the collapse — and most people don't even know it's happening because reptiles lack the charisma of pandas or elephants.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.